Compositions and methods of use for therapeutic antibodies

Details for Australian Patent Application No. 2009272771 (hide)

Owner Novartis AG

Inventors Neugebauer, Julia; Woisetschlaeger, Maximilian; Schaadt, Eveline; Heusser, Christoph; Urlinger, Stefanie

Agent Davies Collison Cave

Pub. Number AU-B-2009272771

PCT Pub. Number WO2010/007082

Priority 09160326.6 15.05.09 EP; 08160671.7 17.07.08 EP

Filing date 15 July 2009

Wipo publication date 21 January 2010

Acceptance publication date 20 September 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 Drugs for skeletal disorders

A61P 37/06 Drugs for immunological or allergic disorders

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/007082 Priority application(s): WO2010/007082

20 September 2012 Application Accepted

  Published as AU-B-2009272771

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272779-Crystalline carbohydrate derivative

2009272764-Selective substance separation using modified magnetic particles